27677842|t|Synthesis, characterization and drug loading property of Monomethoxy-Poly(ethylene glycol)-Poly(ε-caprolactone)-Poly(D,L-lactide) (MPEG-PCLA) copolymers
27677842|a|Amphiphilic block copolymers have attracted a great deal of attention in drug delivery systems. In this work, a series of monomethoxy-poly (ethylene glycol)-poly (ε-caprolactone-co-D,L-lactide) (MPEG-PCLA) copolymers with variable composition of poly (ε-caprolactone) (PCL) and poly (D,L-lactide) (PDLLA) were prepared via ring-opening copolymerization of ε-CL and D,L-LA in the presence of MPEG and stannous octoate. The structure and molecular weight were characterized by nuclear magnetic resonance (NMR) and gel permeation chromatography (GPC). The crystallinity, hydrophilicity, thermal stability and hydrolytic degradation behavior were investigated in detail, respectively. The results showed that the prepared amphiphilic MPEG-PCLA copolymers have adjustable properties by altering the composition of PCLA, which make it convenient for clinical applications. Besides, the drug loading properties were also studied. Docetaxel (DTX) could be entrapped in MPEG-PCLA micelles with high loading capacity and encapsulation efficiency. And all lyophilized DTX -loaded MPEG-PCLA micelles except MPEG-PCL micelles were readily re-dissolved in normal saline at 25 °C. In addition, DTX -loaded MPEG-PCLA micelles showed a slightly enhanced antitumor activity compared with free DTX. Furthermore, DTX micelles exhibited a slower and sustained release behavior in vitro, and higher DTX concentration and longer retention time in vivo. The results suggested that the MPEG-PCLA copolymer with the adjustable ratio of PCL to PDLLA may be a promising drug delivery carrier for DTX.
27677842	32	36	drug	T103	UMLS:C1254351
27677842	57	152	Monomethoxy-Poly(ethylene glycol)-Poly(ε-caprolactone)-Poly(D,L-lactide) (MPEG-PCLA) copolymers	T103	UMLS:C0032521
27677842	153	181	Amphiphilic block copolymers	T103	UMLS:C0032521
27677842	226	247	drug delivery systems	T074	UMLS:C0085104
27677842	275	369	monomethoxy-poly (ethylene glycol)-poly (ε-caprolactone-co-D,L-lactide) (MPEG-PCLA) copolymers	T103	UMLS:C0032521
27677842	399	420	poly (ε-caprolactone)	T103	UMLS:C0137734
27677842	422	425	PCL	T103	UMLS:C0137734
27677842	431	449	poly (D,L-lactide)	T103	UMLS:C0071444
27677842	451	456	PDLLA	T103	UMLS:C0071444
27677842	476	505	ring-opening copolymerization	T038	UMLS:C1880180
27677842	509	513	ε-CL	T103	UMLS:C0908527
27677842	518	524	D,L-LA	T103	UMLS:C0293984
27677842	544	548	MPEG	T103	UMLS:C0066763
27677842	553	569	stannous octoate	T103	UMLS:C0963887
27677842	575	584	structure	T082	UMLS:C0678594
27677842	665	694	gel permeation chromatography	T058	UMLS:C0008559
27677842	696	699	GPC	T058	UMLS:C0008559
27677842	706	719	crystallinity	T103	UMLS:C0444626
27677842	871	903	amphiphilic MPEG-PCLA copolymers	T103	UMLS:C0032521
27677842	962	966	PCLA	T103	UMLS:C1744269
27677842	1033	1037	drug	T103	UMLS:C1254351
27677842	1076	1085	Docetaxel	T103	UMLS:C0246415
27677842	1087	1090	DTX	T103	UMLS:C0246415
27677842	1114	1123	MPEG-PCLA	T103	UMLS:C0032521
27677842	1124	1132	micelles	T103	UMLS:C0025938
27677842	1210	1213	DTX	T103	UMLS:C0246415
27677842	1222	1231	MPEG-PCLA	T103	UMLS:C0032521
27677842	1232	1240	micelles	T103	UMLS:C0025938
27677842	1248	1256	MPEG-PCL	T103	UMLS:C0032521
27677842	1257	1265	micelles	T103	UMLS:C0025938
27677842	1295	1308	normal saline	T103	UMLS:C0445115
27677842	1332	1335	DTX	T103	UMLS:C0246415
27677842	1344	1353	MPEG-PCLA	T103	UMLS:C0032521
27677842	1354	1362	micelles	T103	UMLS:C0025938
27677842	1428	1431	DTX	T103	UMLS:C0246415
27677842	1446	1449	DTX	T103	UMLS:C0246415
27677842	1450	1458	micelles	T103	UMLS:C0025938
27677842	1530	1533	DTX	T103	UMLS:C0246415
27677842	1574	1581	in vivo	T082	UMLS:C1515655
27677842	1614	1633	MPEG-PCLA copolymer	T103	UMLS:C0032521
27677842	1663	1666	PCL	T103	UMLS:C0137734
27677842	1670	1675	PDLLA	T103	UMLS:C0071444
27677842	1695	1716	drug delivery carrier	T103	UMLS:C0013161
27677842	1721	1724	DTX	T103	UMLS:C0246415